Veloxis Pharmaceuticals赞助的临床试验
总计19589个结果
-
Veloxis Pharmaceuticals完全的
-
Veloxis Pharmaceuticals完全的肾功能衰竭美国, 阿根廷, 澳大利亚, 巴西, 法国, 德国, 意大利, 大韩民国, 墨西哥, 新西兰, 波兰, 塞尔维亚, 新加坡, 西班牙, 瑞典
-
Columbia UniversityVeloxis Pharmaceuticals主动,不招人
-
University of Kansas Medical CenterVeloxis Pharmaceuticals完全的
-
Vanderbilt University Medical CenterVeloxis Pharmaceuticals招聘中
-
University of Southern CaliforniaVeloxis Pharmaceuticals招聘中
-
Cedars-Sinai Medical CenterVeloxis Pharmaceuticals主动,不招人
-
Sentara Norfolk General HospitalVeloxis Pharmaceuticals完全的
-
University of California, DavisVeloxis Pharmaceuticals完全的
-
University of Wisconsin, MadisonVeloxis Pharmaceuticals完全的
-
Veloxis PharmaceuticalsCTI Clinical Trial and Consulting Services完全的
-
University of Illinois at ChicagoVeloxis Pharmaceuticals完全的
-
Beth Israel Deaconess Medical CenterVeloxis Pharmaceuticals尚未招聘服药依从性 | 肾移植
-
Medical University of South CarolinaVeloxis Pharmaceuticals完全的
-
University of California, Los AngelesVeloxis Pharmaceuticals主动,不招人
-
The Methodist Hospital Research InstituteVeloxis Pharmaceuticals撤销肾移植急性排斥反应 | 肾脏疾病,终末期 | 供体特异性抗体
-
Veloxis PharmaceuticalsCTI Clinical Trial and Consulting Services完全的
-
Veloxis PharmaceuticalsCTI Clinical Trial and Consulting Services; Aptuit完全的
-
Veloxis PharmaceuticalsCTI Clinical Trial and Consulting Services; Aptuit完全的
-
Novartis PharmaceuticalsChugai Pharmaceutical完全的
-
Novartis PharmaceuticalsChugai Pharmaceutical完全的
-
Novartis PharmaceuticalsPharmaceutical Research Associates撤销